Start page Newsroom All news Newsroom type All Releases Articles year All years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 Orion is developing the Finnish life science industry in a unique collaboration project 6/3/2024 Press release Orion publishes Interim Report for January–March 2024 and holds a webcast on 25 April 2024 4/11/2024 Press release The change negotiations concerning Orion’s Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plant 3/22/2024 Press release Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally 2/22/2024 Press release Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland 2/19/2024 Press release Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024 1/29/2024 Press release Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain 1/29/2024 Press release Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024 1/26/2024 Press release Orion and Glykos announce research collaboration and licensing agreement to develop next-generation ADCs 1/8/2024 Press release Orion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate Cancer 1/5/2024 Press release NEJM Evidence publishes results from Phase I/IIa CYPIDES trial with ODM-208 12/27/2023 Press release Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov database 11/21/2023 Press release Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution) 11/20/2023 Press release Orion Research Foundation grants EUR 1,112,000 for research in 2024 11/15/2023 Press release Orion publishes Interim Report for January–September 2023 on Thursday 26 October 2023 10/16/2023 Press release European Commission approval of Ztalmy® (ganaxolone) for the adjunctive treatment of epileptic seizures associated with CDKL5 deficiency disorder 7/31/2023 Press release Orion publishes Half-Year Financial Report for January–June 2023 on Monday 17 July 2023 7/4/2023 Press release Orion invests EUR 30 million to increase production capacity in Finland 6/28/2023 Press release